DEXCOM, INC.

Public Equity (NASDAQ)Medical DevicesHealthcarePublic Company

📍 San Diego, CA, USA• Founded 1999

StreetZero Signal 58

Be the first to signal interest

About DEXCOM, INC.

Dexcom, Inc. develops, manufactures, and distributes continuous glucose monitoring systems for people with diabetes. Its products include wearable sensors, transmitters, and mobile apps that deliver real-time glucose data and alerts. The company is publicly traded on NASDAQ under the ticker DXCM and is headquartered in San Diego, California.

LATEST FUNDINGRule 144

$202K

Announced 2026-10-27

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for DEXCOM, INC..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES—

FOUNDED1999

HQSan Diego, CA, USA

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Publicly traded on NASDAQ under ticker DXCM
Specializes in continuous glucose monitoring technology
Headquartered in San Diego, California

Ask StreetZero about DEXCOM, INC.

Put our AI to work on this deal.

What is DEXCOM, INC.'s value proposition?Who are DEXCOM, INC.'s competitors?Why does this raise matter?Summarize DEXCOM, INC. for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Paylocity Holding Corporation

$66.0M

BENTLEY SYSTEMS INC

$67.5M

Crowdstrike Holdings, Inc.

$141.0M

Palo Alto Networks Inc

$201.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.